A study harnessing a successful treatment for lymphoma and applying it to other cancers promises a breakthrough in how to attack a range of tumours using the body’s own immune system.
A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...
One person’s side effect could be another person’s treatment if we expand our perspective on small molecule drug targets, ...
Investor's Business Daily on MSN
Why Gene-Editing Giants Crispr Therapeutics And Intellia Therapeutics Diverged
Crispr stock reversed lower Monday, while Intellia stock surged, on promising updates for their gene-editing efforts.
Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...
The Cancer Gene Therapy Market is poised for growth driven by rising cancer burdens, demand for precision therapies, and ...
Clustered regularly interspaced palindromic repeats(CRISPR) gene editing, known for its precision, is revolutionizing tumor research and treatment. This article covers the evolution of the CRISPR ...
In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at their genetic source.
Thus, this new site-specific and cassette mutagenesis method is highly efficient, fast and versatile, likely resulting in its wide use for typical ...
CHINO HILLS, CALIFORNIA / ACCESS Newswire / November 6, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in ...
The Chosun Ilbo on MSN
Samsung Invests in U.S. Gene-Editing Firm Arbor Biotechnologies
Samsung is proceeding with an investment in U.S.-based Arbor Biotechnologies (Arbor Bio), a company specializing in gene-editing technology. The move aims to explore high-growth new business ...
Samsung said on the 30th that it will invest in Arbor Biotechnologies (hereafter Arbor Biotechnologies), a U.S. company with gene-editing technology, through the Life Science Fund, which was created ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results